FOR UK MEDICAL AND TRADE MEDIA ONLY Lupin's Namuscla (mexiletine) is recommended by NICE for treatment of symptomatic myotonia in adults with non-dystrophic myotonic disorders (NDM) Slough
Investegate announcements from Lupin Ltd, Lupin’s Namuscla® (mexiletine) is recommended by NICE for treatment of symptomatic myotonia in adults with non-dystrophic myotonic disorders (NDM)